Repeatability of Electroretinogram and Visual Evoked Potential
1 other identifier
interventional
250
1 country
1
Brief Summary
To assess repeatability of electroretinogram and visual evoked potential in clinical practice
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2022
CompletedFirst Submitted
Initial submission to the registry
April 7, 2022
CompletedFirst Posted
Study publicly available on registry
April 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2022
CompletedApril 19, 2022
April 1, 2022
7 months
April 7, 2022
April 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Repeatability of ERG amplitude.
ERG amplitude measured in nano volt (nV).
Changes from baseline measurements and at one week.
Secondary Outcomes (1)
Repeatability of ERG latency.
Changes from baseline measurements and at one week.
Other Outcomes (2)
Repeatability of VEP amplitude.
Changes from baseline measurements and at one week.
Repeatability of VEP latency.
Changes from baseline measurements and at one week.
Study Arms (2)
Electroretinogram test (ERG)
ACTIVE COMPARATORERG test will be done for each subject twice and compare the results to assess repeatability of the test.
Visual evoked potential test (VEP)
ACTIVE COMPARATORVEP test will be done for each subject twice and compare the results to assess repeatability of the test.
Interventions
Applying electrodes to assess retinal function
Applying electrodes to assess visual pathway function
Eligibility Criteria
You may qualify if:
- Normal subjects visit banha university hospital seeking regular checkup and subjects asked for ERG and VEP as a pre-occupational examination.
You may not qualify if:
- Patients previously diagnosed with any retinal disease or visual pathway disease that may affect ERG and VEP tests.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Benha Universitylead
Study Sites (1)
Ahmed Abdelshafy Tabl
Banhā, Benha, 13511, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ahmed A Abdelshafy, MD
Benha University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Ophthalmology
Study Record Dates
First Submitted
April 7, 2022
First Posted
April 19, 2022
Study Start
April 1, 2022
Primary Completion
October 30, 2022
Study Completion
October 30, 2022
Last Updated
April 19, 2022
Record last verified: 2022-04